These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 22394269)
1. Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale. Fehr T; Gaspert A Transpl Int; 2012 Jun; 25(6):623-32. PubMed ID: 22394269 [TBL] [Abstract][Full Text] [Related]
2. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198 [TBL] [Abstract][Full Text] [Related]
3. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment. Stegall MD; Gloor JM Curr Opin Organ Transplant; 2010 Feb; 15(1):8-10. PubMed ID: 19890210 [TBL] [Abstract][Full Text] [Related]
4. The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection. Ahmed T; Senzel L J Clin Apher; 2012; 27(4):173-7. PubMed ID: 22411078 [TBL] [Abstract][Full Text] [Related]
5. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection. Hardinger KL; Murillo D Clin Transpl; 2011; ():401-8. PubMed ID: 22755438 [TBL] [Abstract][Full Text] [Related]
6. Management of antibody-mediated rejection in transplantation. Sadaka B; Alloway RR; Woodle ES Surg Clin North Am; 2013 Dec; 93(6):1451-66. PubMed ID: 24206861 [TBL] [Abstract][Full Text] [Related]
15. Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant. Ruangkanchanasetr P; Satirapoj B; Termmathurapoj S; Namkhanisorn K; Suaywan K; Nimkietkajorn V; Luesutthiviboon L Exp Clin Transplant; 2014 Aug; 12(4):328-33. PubMed ID: 25095710 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of bortezomib for reducing donor-specific antibodies in children and adolescents on a steroid minimization regimen. Nguyen S; Gallay B; Butani L Pediatr Transplant; 2014 Aug; 18(5):463-8. PubMed ID: 24814755 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation. Lee J; Kim BS; Park Y; Lee JG; Lim BJ; Jeong HJ; Kim YS; Huh KH Yonsei Med J; 2015 Nov; 56(6):1638-42. PubMed ID: 26446648 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib rescue in refractory acute humoral rejection--report of a case. Shapiro R; Basu A; Zeevi A; Lunz J; Mapara M; Randhawa P; Morgan C; Tan HP; Sharma V Clin Transpl; 2009; ():431-2. PubMed ID: 20524310 [No Abstract] [Full Text] [Related]
19. Proteasome inhibitor treatment of antibody-mediated allograft rejection. Woodle ES; Alloway RR; Girnita A Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709 [TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options. Kim M; Martin ST; Townsend KR; Gabardi S Pharmacotherapy; 2014 Jul; 34(7):733-44. PubMed ID: 24753207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]